ArticleJournal of medical virology2026
Genomic Characterization and Structural Insights Into the Evolution of Influenza A(H1N1)pdm09 in Northeast India From 2009 to 2024.
Article in Journal of medical virology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Genomic Characterization and Structural Insights Into the Evolution of Influenza A(H1N1)pdm09 in Northeast India From 2009 to 2024.Journal of medical virology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Influenza A(H1N1)pdm09 continues to evolve through antigenic drift, posing challenges to vaccine effectiveness. The present study investigated the evolutionary dynamics, glycosylation patterns, and immunological features of the hemagglutinin (HA) gene of Influenza A(H1N1)pdm09 from the region. A total of 120 positive samples collected between 2022 and 2024 were sequenced using the Illumina MiSeq platform alongside previously generated HA sequences from the laboratory during 2009-2019. Mutational analysis was performed against the reference strain (A/California/07/2009) and the vaccine strain (A/Wisconsin/67/2022), followed by phylogenetic, structural, N-glycosylation, and epitope analysis using bioinformatics tools. Several persistent mutations (P100S, S220T, R240Q, I338V, E391K) were observed across study years, while substitutions such as S101N, D114N, A273T, K300E, S468N, E516K, and K180Q were consistently detected after 2015. Recent circulating strains (2022-2024) acquired additional mutations (K71Q, N146D, K147N, L178I, N173K, and A203T) and predominantly exhibited S202I rather than the earlier S202T substitution. Phylogenetically, these strains clustered within clade 6B.1 A.5a.2a. The presence of an additional N-glycosylation site at residue 179 after 2017 may suggest immune-driven selection. Notably, T137A, K186Q, and E277D substitutions identified in 2024 Influenza A(H1N1)pdm09 strains were associated with the loss of predicted epitope-binding regions relative to the vaccine strain A/Wisconsin/67/2022. These amino acid changes suggest potential alterations in antigenic structure that may influence immune recognition. No differences in mutation distribution were observed between the indoor and outdoor cases. Overall, the study represents the first long-term genomic surveillance of Influenza A(H1N1)pdm09 from Northeast India and demonstrates continuous genetic diversification and evolutionary dynamics of circulating Influenza A(H1N1)pdm09 strains.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.